Nature Medicine · 2023 · 61 citations · 26 references
MedicineOncologyPharmacologyCancer PharmacologyMolecular OncologyNeoplasiaCancer ImmunotherapyCancer ProgressionLung CancerLung Cancer PharmacotherapyMalignant NeoplasmsPersonalized Cancer TherapyHer2 InhibitorsHer2 Receptor SignalingHer2 Receptor TargetingHuman Epidermal Growth Factor Receptor 2-Targeted TherapyNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentTrastuzumab Resistance
26
Trastuzumab Deruxtecan in <i>HER2</i> -Mutant Non–Small-Cell Lung Cancer
Bob T. Li, Egbert F. Smit, Yasushi Goto et al. · New England Journal of Medicine · 2021 · 980 citations · Full text
Medicine, Oncology, Pharmacology +16
Intragenic ERBB2 kinase mutations in tumours
Philip Stephens, Chris Hunter, Graham R. Bignell et al. · Nature · 2004 · 791 citations
Michael Offin, Joseph M. Chan, Megan Tenet et al. · Journal of Thoracic Oncology · 2019 · 448 citations · Full text